Navigation Links
Angeion Corporation to Report Third Quarter Fiscal Year 2011 Financial Results on Thursday, September 1, 2011
Date:8/25/2011

SAINT PAUL, Minnesota, Aug. 25, 2011 /PRNewswire/ -- Angeion Corporation (NASDAQ: ANGN) today scheduled a conference call to discuss its financial results for the third quarter of fiscal year 2011, ended July 31, 2011. The call will be at 4:30 p.m. ET on Thursday, September 1, 2011. The Company will report financial results for the third quarter of fiscal year 2011 after the market closes on Thursday, September 1, 2011.

Those wishing to participate can dial (877) 317-6789 or (412) 317-6789 to access the conference call, or listen via a live Internet webcast on the Company's website at www.angeion.com. A replay of the conference call will be available by dialing (877) 344-7529 or (412) 317-0088, confirmation code 10003350, through September 7, 2011. A webcast replay of the conference call will be accessible on the Company's website at www.angeion.com for 30 days.

About Angeion Corporation Founded in 1986, Angeion Corporation acquired Medical Graphics Corporation in December 1999. Medical Graphics develops, manufactures and markets non-invasive cardiorespiratory diagnostic systems that are sold under the MedGraphics (www.medgraphics.com) and New Leaf (www.newleaffitness.com) brand names. These cardiorespiratory product lines provide solutions for disease detection, integrated care, and wellness across the entire spectrum of health – whether managing chronic illness, promoting fitness, or training for the Olympics. The Company's products are sold internationally through distributors and in the United States through a direct sales force that targets heart and lung specialists located in hospitals, university-based medical centers, medical clinics and physicians' offices, pharmaceutical companies, medi
'/>"/>

SOURCE Angeion Corporation
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
2. CEL-SCI Corporation Releases Letter to Shareholders
3. Alfacell Corporation to Present at UBS Global Life Sciences Conference
4. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
5. Genaera Corporation Presents Preclinical Trodusquemine (MSI-1436) Data at the North American Association for the Study of Obesity Annual Meeting
6. Genaera Corporation Presents Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting
7. The Quigley Corporation Reports Third Quarter Results, Increases Investment in Pharmaceutical R&D for Diabetic Neuropathy
8. Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting
9. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation
10. Immunosyn Corporation Releases SF-1019 Study Results
11. AmpliMed Corporation Announces Promising 1-year Survival Data from Phase I/II Study of Amplimexon(R) in Metastatic Malignant Melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... 2013  Boehringer Ingelheim will contribute to advancing ... American Thoracic Society International Conference (ATS 2013) in ... – 22. Data will highlight research ... of chronic obstructive pulmonary disease (COPD) [Spiriva® HandiHaler® ... compounds for asthma, idiopathic pulmonary fibrosis (IPF) and ...
(Date:5/17/2013)...  Sanofi (EURONEXT: SAN and NYSE: SNY ) ... , examining the selective JAK2 inhibitor SAR302503 for ... groups. The primary endpoint assessed the proportion of patients ... reported in previous trials, the most common adverse events ... be presented at an upcoming medical congress. ...
(Date:5/17/2013)...  Boston Scientific Corporation (NYSE: BSX ) ... Program May 21-24 in Paris . ... rich and diversified set of data this year at ... global chief medical officer, Boston Scientific.  "The primary endpoint ... NG PROMUS trial, which evaluated our Promus PREMIER ™ ...
Breaking Medicine Technology:Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 2Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 3Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 4Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 5Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 6Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 7Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 8Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 2Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 4Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 5Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 6Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 7Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 8
... -- Chindex International, Inc. (NASDAQ: ... care services in China through the operations of United ... and affiliated ambulatory clinics, today announced that the Company ... and first half of 2011, which ended June 30, ...
... Apnex Medical, Inc., received investigational device exemption (IDE) approval ... begin a clinical study to evaluate the safety and ... treat obstructive sleep apnea (OSA). Data from this clinical ... application for the HGNS System to the FDA. ...
Cached Medicine Technology:Chindex International, Inc. to Report Financial Results for the Second Quarter and First Half of 2011 2Apnex Medical, Inc. Receives FDA Approval for Pivotal Clinical Study for Obstructive Sleep Apnea 2Apnex Medical, Inc. Receives FDA Approval for Pivotal Clinical Study for Obstructive Sleep Apnea 3
(Date:5/18/2013)... Morro Bay, CA (PRWEB) May 18, 2013 ... salon , has recently completed a stylish renovation that ... and advanced specialties. , From the ground up, this ... been improved with fresh flooring, soothing colors and comfortable ... have been installed, including an Apilus epilator machine. ...
(Date:5/18/2013)... Spectrum Surgical Instruments will attend the ... Austin, TX where thousands of GI nursing professionals ... , Spectrum Surgical/STERIS will feature its flexible ... capabilities and certified pre-owned equipment. Attendees will also ... instrument care of flexible endoscopes. , Visit ...
(Date:5/18/2013)... Miami, FL (PRWEB) May 18, 2013 ... accessories, is now offering its customers an attractive 25% ... Corkscrew. , Customers can now purchase this ... safe and secure online transactional process. The online store ... from the date of order placement. , A ...
(Date:5/18/2013)... UT (PRWEB) May 18, 2013 Medical device ... orders for its much anticipated mobility aid with its namesake, ... create a hands-free crutch alternative that injured individuals ... broken ankle, for example, can remain active and walk during ... is using its reservation system to ensure those who need ...
(Date:5/17/2013)... 18, 2013. Chronic trauma can inflict lasting damage to ... studies of people with post-traumatic stress disorder, or PTSD, ... in response to stressful tasks, such as recalling a ... threatening face. Now, researchers at NYU School of Medicine ... the brains of combat veterans with PTSD in the ...
Breaking Medicine News(10 mins):Health News:Rio Salon and Spa, a Beauty Salon in Morro Bay, Undergoes Makeover 2Health News:Spectrum Surgical Attends Society of Gastroenterology Nurses and Associates' (SGNA) 40th Annual Conference in Austin, TX 2Health News:Now Save 25% on Franmara Dynamo Electric Wine Bottle Opener at Wine World Accessories 2Health News:FlexLeg Begins Offering New Mobility Aid 2Health News:For combat veterans suffering from post-traumatic stress disorder, 'fear circuitry' in the brain never rests 2
... Jan. 28, 2009 Physical therapists at UT Southwestern ... people recovering from neurological injuries such as strokes and traumatic ... repeatedly practice movements needed to regain arm strength and movement. ... sites testing how the Armeo device, with its virtual environment ...
... with AsthmaWASHINGTON, Jan. 28 St. Louis, MO, is ranked ... to live with asthma in the U.S. (1) - according ... conducted the study. This ranking was determined based on an ... U.S. metro areas. (1) St. Louis was ranked No.1 this ...
... Relocated to Adjacent Proton Site in Warrenville CHICAGO, ... Illinois state approval on its plans to build ... in Warrenville. The Illinois Health Facilities Planning Board ... the project,s Certificate of Need application during today,s ...
... disease that,s harder to control, study says , , TUESDAY, ... of tuberculosis patients in the United States who say ... and difficult to treat than other TB patients, a ... patients aged 15 or older. Of those patients, 28,650 ...
... and Republican Party on Wrong TrackSACRAMENTO, Calif., Jan. 27 ... claimed that the Medicaid Family Planning State Option, a ... millions of women, would cost hundreds of millions of ... misleading attacks and partisan politics, was dropped from the ...
... ReportedCARLSBAD, Calif., Jan. 27 Jenny Craig, Inc. ... management, today announced a voluntary recall of its ... (UPC Code 655447009347) for U.S and P.R. distribution ... MAY2409BLO, MAY2509BLO, MAY2509ALO, MAY2609ALO, & MAY2609BLO, because the ...
Cached Medicine News:Health News:Physical therapists test mechanical arm to help patients recover from stroke, traumatic brain injury 2Health News:Physical therapists test mechanical arm to help patients recover from stroke, traumatic brain injury 3Health News:St. Louis Named Top Asthma Capital for 2009 2Health News:St. Louis Named Top Asthma Capital for 2009 3Health News:St. Louis Named Top Asthma Capital for 2009 4Health News:St. Louis Named Top Asthma Capital for 2009 5Health News:St. Louis Named Top Asthma Capital for 2009 6Health News:Central DuPage Hospital Wins State Approval to Build Cancer Center 2Health News:Central DuPage Hospital Wins State Approval to Build Cancer Center 3Health News:Substance Abuse Hinders TB Treatment 2Health News:Family Planning Provision Wrongfully Removed From Economic Stimulus Package 2Health News:Jenny Craig Announces Nationwide Voluntary Recall of Jenny's Cuisine(R) Anytime Peanut Butter Flavor Nutritional Bars Due to Possible Peanut Corporation of America (PCA) Contamination and Potential Health Risk 2
Used for antegrade placement of a safety wire guide prior to endourological procedures. Supplied sterile in peel-open packages. Intended for one-time use....
Supplied sterile in peel-open packages. Intended for one-time use....
Supplied sterile in peel-open packages. Intended for one-time use....
... exchange in endourological procedures. The increased inner ... utilization of an extra heavy duty mandril ... flexible tip. The proximal end of this ... wire guide manufactured by Cook®. Supplied sterile ...
Medicine Products: